Source: PR Newswire

Press Release: Sierra Oncology : Sierra Oncology Launches Campaign Exploring Non-Dilutive Strategic Options to Support Development of its DDR Assets

- Corporate prioritization of portfolio to focus resources on advancement of momelotinib - - Exploring non-dilutive options to support future continued development of SRA737 and SRA141 - VANCOUVER, June 27, 2019 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Stephen Dilly's photo - President & CEO of Sierra Oncology, Inc.

President & CEO

Stephen Dilly

CEO Approval Rating


Sierra is a clinical-stage drug development company that researches, develops and commercializes therapeutics for the treatment of cancer. Read more